Chromatin Immunoprecipitation (ChIP) News and Research

RSS

New prototype sensor aids in the rapid assessment of disease severity

Scientists have developed a prototype sensor that could help doctors rapidly measure adenosine triphosphate (ATP) and lactate levels in blood samples from patients, aiding in the rapid assessment of the severity of some diseases.

25 Feb 2022

Health care firms were pushed to confront racism. Now some are investing in Black startups.

Marcus Whitney stands out in Nashville's $95 billion health care sector as an investor in startups. In addition to co-founding a venture capital firm, he's organized an annual health tech conference and co-founded the city's professional soccer club.

25 Feb 2022

3D model of living brain cancer developed as a potential alternative for drug testing without animals

As a potential alternative for drug testing without lab animals, researchers at KTH Royal Institute of Technology developed and successfully tested a 3D model of living brain cancer that surmounts one of the biggest challenges in tissue engineering.

23 Feb 2022

Automata raises US $50 million in series B financing to accelerate automation in life science

Automata – the automation company helping life sciences rapidly innovate, diagnose and discover at scale – today announces it has raised US$50 million in Series B funding.

From Automata 22 Feb 2022

Prescribing of ineffective COVID drugs could have been influenced by political affiliation

Two treatments that have been shown to be ineffective against COVID-19—hydroxychloroquine and ivermectin—were more heavily prescribed in the latter part of 2020 in U.S. counties with a higher Republican vote share in the 2020 presidential election, according to a new research letter co-authored by researchers from Harvard T.H. Chan School of Public Health.

18 Feb 2022

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Optical genome mapping involves the extraction of very long DNA molecules, for example routinely collected blood samples or bone marrow material from patients.

17 Feb 2022

Medical boards pressured to let it slide when doctors spread covid misinformation

Tennessee's Board of Medical Examiners unanimously adopted in September a statement that said doctors spreading covid misinformation — such as suggesting that vaccines contain microchips — could jeopardize their license to practice.

15 Feb 2022

Why millions on Medicaid are at risk of losing coverage in the months ahead

The Biden administration and state officials are bracing for a great unwinding: millions of people losing their Medicaid benefits when the pandemic health emergency ends. Some might sign up for different insurance. Many others are bound to get lost in the transition.

14 Feb 2022

Regulatory sequences in the genomes of mammals help explain how cancer invades normal tissues

Researchers from UConn Heath and Yale University have made new advances connecting the evolution of pregnancy and cancer metastasis.

8 Feb 2022

Scientists test a tiny biosensor to detect biomarkers linked to traumatic brain injuries

Scientists have successfully tested in the lab a tiny biosensor they developed that can detect biomarkers tied to traumatic brain injuries.

3 Feb 2022

Nanomedicine can be improved with proper and more predictive in vitro assays

Messenger RNA (mRNA) vaccines are a prime example of the promising field of nanomedicine. But progress in the design and application of nanoparticles as efficient delivery vehicles for biopharmaceutics containing nucleic acid or protein drug substances is, unfortunately, remarkably slow.

1 Feb 2022

Northwestern and partners are part of mega NIH program to investigate precision nutrition

Northwestern, the University of Chicago, Illinois Institute of Technology, University of Illinois, Chicago and Rush University are part of a mega National Institutes of Health (NIH) $170 million program that is the first comprehensive study to investigate precision nutrition.

27 Jan 2022

AMSBIO Expands EU Operations

...

From AMS Biotechnology 26 Jan 2022

With a vaccine mandate looming, nursing homes face more staffing problems

Jamie Smith, a staffing agency nurse who loves end-of-life care, said she has been warmly welcomed by staffers and residents at Frontier Health & Rehabilitation in this conservative St. Louis suburb.

25 Jan 2022

Why Medicare doesn’t pay for rapid at-home covid tests

What group is especially vulnerable to the ravages of covid-19 even if fully vaccinated and boosted? Seniors. And who will have an especially tough time getting free at-home covid tests under the Biden administration's plan? Yes, seniors.

24 Jan 2022

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

20 Jan 2022

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

A recent review discusses the engineering versatility of polymeric nanoparticles - making a good therapeutic alternative against coronavirus diseases.

19 Jan 2022

FAU receives $1.3 million NIH grant for automated HIV self-testing assay

As of 2020, there were 37.7 million people globally living with HIV and 680,000 people died from AIDS-related illnesses last year. Since the start of the epidemic, more than 36.3 million people have died from AIDS-related illnesses.

13 Jan 2022

Newly designed biochip simplifies the process of manufacturing in vitro skin in the laboratory

Researchers from the Universidad Carlos III de Madrid, the Universidad Politécnica de Madrid (UPM) and other entities have designed a new biochip, a device that simplifies the process of manufacturing in vitro skin in the laboratory and other complex multi-layer tissues.

12 Jan 2022

Providing recombinant antibody services and more within Europe

In this interview, News-Medical talks to Dr. Zhang Linlin, Technical Specialist at Sino Biological Europe, about their recombinant antibody services and more that they can provide within Europe. Image credit: Corona Borealis Studio/Shutterstock.com

From Sino Biological Inc. 11 Jan 2022